| Date | Title | | | 03/11/10 | NuVasive to Present at the Roth OC Growth Stock Conference| SAN DIEGO, March 11, 2010 /PRNewswire via COMTEX/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Patrick F. Williams, Vice President of Finance and Investor Relations, is scheduled to present at the 22nd Annual Roth OC Growth Stock Conference at the Ritz-Carlton Hotel in Laguna Niguel, California, on Tuesday, March 16, 2010, at 1:30 p.m. PST.
A live webcast of the presenta... |
|  | | 03/05/10 | NuVasive to Present at the Canaccord Adams Musculoskeletal Conference and the Cowen Annual Health Care Conference| SAN DIEGO, March 5, 2010 /PRNewswire via COMTEX/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Patrick F. Williams, Vice President of Finance and Investor Relations, is scheduled to present at the Canaccord Adams Musculoskeletal Conference at the Sheraton Hotel in New Orleans, Louisiana, on Tuesday, March 9, 2010, at 9:00 a.m. ET. Mr. Williams is also scheduled to present... |
|  | | 02/26/10 | NuVasive Announces Additional Insurance Provider XLIF(R) Policy Reversal| SAN DIEGO, Feb 26, 2010 /PRNewswire via COMTEX/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that United Healthcare changed its lumbar spinal fusion policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as unproven.
The updated policy removes XLIF from the ... |
|  | | 02/26/10 | NuVasive Announces Insurance Provider Policy Reversal to Cover XLIF(R)| SAN DIEGO, Feb 26, 2010 /PRNewswire via COMTEX/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Aetna changed its spinal surgery policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as experimental and investigational.
The updated policy states that late... |
|  | | 02/25/10 | NuVasive Reports Fourth Quarter and Full Year 2009 Financial Results| - Full year 2009 total revenue of $370.3 million; up 48.1% from the full year 2008 - Fourth quarter total revenue of $106.9 million; up 43.4% from fourth quarter 2008 and up 12.7% from third quarter 2009 - GAAP earnings of $2.3 million, or $0.06 per share, for the fourth quarter and $5.8 million, or $0.15 per share, for the full year - Earnings, excluding certain adjustments, of $4.2 million, or $0.11 per share, for the fourth quarter and $12.3 million, or $0.32 per share, for the full year - Op... |
|  | | 01/29/10 | NuVasive Announces Preliminary Unaudited Full Year 2009 Financial Results| --Anticipates Full Year 2009 Revenue of Approximately $370 Million --Announces Full Year 2010 Revenue Guidance of $480 Million to $500 MillionSAN DIEGO, Jan 29, 2010 /PRNewswire via COMTEX/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, today announced preliminary unaudited financial results for the full year ended December 31, 2009.
NuVasive anticipates full year 2009 revenue of approximatel... |
|  | | 01/05/10 | NuVasive to Present at the 28th Annual J.P. Morgan Healthcare Conference| SAN DIEGO, Jan 05, 2010 /PRNewswire-FirstCall via COMTEX/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Alex Lukianov, Chairman and Chief Executive Officer, and Michael J. Lambert, Executive Vice President and Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco, California, on Tuesday, Januar... |
|  |
|